Abstract:Background PA-HSOS is a rare disease and there is no specific treatment for PA-HSOS. Anticoagulant, antithrombotic and microcirculation therapy can alleviate the progression of PA-HSOS. The application of rivaroxaban in patients with PA-HSOS has not yet been reported. The aim of this study was to analyze the efficacy and safety of rivaroxaban in the treatment of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndromecaused by Gynura segetum (PA-HSOS) .
MethodsA retrospective analysis was conduct… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.